Repligen
Repligen is a biotechnology company that develops and distributes biologic drugs and monoclonal antibodies.
Business Model: B2C
Revenue: $801.3M
Employees: 1,001-5,000
Industries / Tags:
Detailed Repligen Information
Geographic Data
Address: 41 Seyon Street
City: Waltham
State: MA
Zip: 02453
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$312M
Raised Total:$291M
Social
Metrics
996,808Website Global Rank
33,523Website Monthly Traffic
Twitter Followers
Description
Repligen is a biotechnology company that develops and distributes biologic drugs and monoclonal antibodies.
Contact Phone:
+17812500111
Contact Email:
Repligen went public on 5/9/1986 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/9/1986
Ticker Symbol:
RGEN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 9/2021 | Avitide | |
| 6/2021 | Polymem | |
| 10/2020 | ARTeSYN Biosolutions | |
| 4/2019 | C Technologies | |
| 6/2017 | Spectrum Laboratories | |
| 12/2016 | TangenX Technology Corp | |
| 4/2016 | Atoll GmbH | |
| 10/2011 | Novozymes Biopharma Sweden |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
